Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-026868
Filing Date
2024-02-07
Accepted
2024-02-07 17:34:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11397
2 GRAPHIC g602978g0208033521889.jpg GRAPHIC 2187
3 GRAPHIC g602978g0208033522223.jpg GRAPHIC 2301
  Complete submission text file 0001193125-24-026868.txt   18973
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)